These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22848254)

  • 1. Growth inhibition and enhanced chemosensitivity induced by down-regulation of Aurora-A in human renal cell carcinoma Caki-2 cells using short hairpin RNA.
    Terakawa T; Miyake H; Kumano M; Fujisawa M
    Oncol Lett; 2011 Jul; 2(4):713-717. PubMed ID: 22848254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer model.
    Kumano M; Miyake H; Terakawa T; Furukawa J; Fujisawa M
    BJU Int; 2010 Jul; 106(1):121-7. PubMed ID: 19912186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma.
    Tanaka E; Hashimoto Y; Ito T; Kondo K; Higashiyama M; Tsunoda S; Ortiz C; Sakai Y; Inazawa J; Shimada Y
    Clin Cancer Res; 2007 Feb; 13(4):1331-40. PubMed ID: 17317845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model.
    Sakai I; Miyake H; Terakawa T; Fujisawa M
    Cancer Sci; 2011 Apr; 102(4):769-75. PubMed ID: 21214673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin.
    Zellweger T; Miyake H; July LV; Akbari M; Kiyama S; Gleave ME
    Neoplasia; 2001; 3(4):360-7. PubMed ID: 11571636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
    Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
    Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma.
    Wakita T; Hayashi T; Nishioka J; Tamaru H; Akita N; Asanuma K; Kamada H; Gabazza EC; Ido M; Kawamura J; Suzuki K
    Int J Cancer; 2004 Feb; 108(4):516-23. PubMed ID: 14696115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced sensitivity to sorafenib by inhibition of Akt1 expression in human renal cell carcinoma ACHN cells both in vitro and in vivo.
    Tei H; Miyake H; Fujisawa M
    Hum Cell; 2015 Jul; 28(3):114-21. PubMed ID: 25862630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of clusterin expression enhanced cisplatin-induced cytotoxicity on renal cell carcinoma cells.
    Lee CH; Jin RJ; Kwak C; Jeong H; Park MS; Lee NK; Lee SE
    Urology; 2002 Sep; 60(3):516-20. PubMed ID: 12350509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
    Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
    Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines.
    Tochizawa S; Masumori N; Yanai Y; Ohmoto Y; Yabuuchi Y; Tsukamoto T
    Biomed Res; 2008 Dec; 29(6):271-8. PubMed ID: 19129670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Targeting Clusterin Using OGX-011 on Antitumor Activity of Temsirolimus in a Human Renal Cell Carcinoma Model.
    Nishikawa M; Miyake H; Gleave M; Fujisawa M
    Target Oncol; 2017 Feb; 12(1):69-79. PubMed ID: 27526062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells.
    Long M; Yin G; Liu L; Lin F; Wang X; Ren J; Wei J; Dong K; Zhang H
    Cancer Gene Ther; 2012 Apr; 19(4):271-81. PubMed ID: 22281755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models.
    Schirner M; Hoffmann J; Menrad A; Schneider MR
    Clin Cancer Res; 1998 May; 4(5):1331-6. PubMed ID: 9607594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of lncRNA HOTAIR on the radiosensitivity of HCCLM3 cells].
    Zhai JJ; Du XR; Li CX
    Zhonghua Yi Xue Za Zhi; 2020 May; 100(18):1419-1425. PubMed ID: 32392994
    [No Abstract]   [Full Text] [Related]  

  • 16. Up-regulation of connexin 32 gene by 5-aza-2'-deoxycytidine enhances vinblastine-induced cytotoxicity in human renal carcinoma cells via the activation of JNK signalling.
    Takano Y; Iwata H; Yano Y; Miyazawa M; Virgona N; Sato H; Ueno K; Yano T
    Biochem Pharmacol; 2010 Aug; 80(4):463-70. PubMed ID: 20510207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.
    Sato H; Hagiwara H; Senba H; Fukumoto K; Nagashima Y; Yamasaki H; Ueno K; Yano T
    Mol Carcinog; 2008 Jun; 47(6):403-9. PubMed ID: 18058801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) is Underexpressed in Clear Cell Renal Cell Carcinoma Tissue and Transfection and Overexpression in Caki-1 Cells Inhibits Cell Proliferation and Increases Apoptosis.
    He D; Yu Z; Liu S; Dai H; Xu Q; Li F
    Med Sci Monit; 2018 Nov; 24():8391-8400. PubMed ID: 30459299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cafestol, a coffee-specific diterpene, induces apoptosis in renal carcinoma Caki cells through down-regulation of anti-apoptotic proteins and Akt phosphorylation.
    Choi MJ; Park EJ; Oh JH; Min KJ; Yang ES; Kim YH; Lee TJ; Kim SH; Choi YH; Park JW; Kwon TK
    Chem Biol Interact; 2011 Apr; 190(2-3):102-8. PubMed ID: 21334318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NGAL can alternately mediate sunitinib resistance in renal cell carcinoma.
    Yu DS; Wu CL; Ping SY; Huang YL; Shen KH
    J Urol; 2014 Aug; 192(2):559-66. PubMed ID: 24423438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.